Skip to Main Content

Paper Details

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.
Nat Commun
79
2016
extracapsular prostate cancer, extraprostatic and organ-confined prostate cancers, men, patient, prostate cancer
Biomarkers, Humans, Liquid Biopsy, Male, Mass Spectrometry, Middle Aged, Prostate, Prostatic Neoplasms, Proteome, Proteomics
Author NameAffiliation
Yunee KimUniversity of Toronto
Jouhyun JeonOntario Institute for Cancer Research
Salvador Mejia-GuerreroPrincess Margaret Cancer Center, University Health Network
Cindy Q YaoUniversity of Toronto
Cindy Q YaoOntario Institute for Cancer Research
Vladimir IgnatchenkoPrincess Margaret Cancer Center, University Health Network
Julius O NyalwidheEastern Virginia Medical School
Julius O NyalwidheLeroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School
Anthony O GramoliniUniversity of Toronto
Anthony O GramoliniUniversity of Toronto
Raymond S LanceLeroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School
Raymond S LanceEastern Virginia Medical School
Dean A TroyerEastern Virginia Medical School
Dean A TroyerLeroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School
Richard R DrakeMedical University of South Carolina
Paul C BoutrosUniversity of Toronto
Paul C BoutrosOntario Institute for Cancer Research
Paul C BoutrosUniversity of Toronto
Oliver J SemmesEastern Virginia Medical School
Oliver J SemmesLeroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School
Thomas KislingerUniversity of Toronto
Thomas KislingerPrincess Margaret Cancer Center, University Health Network
Thomas KislingerUniversity of Toronto
Thomas KislingerPrincess Margaret Cancer Center, University Health Network
  • 1 - 24

Datasets

Release 1.2